Skip to main content Accessibility help
×
Home

Research needs in antibiotic stewardship

  • Andrew M. Morris (a1) (a2), Michael S. Calderwood (a3), Scott K. Fridkin (a4), Daniel J. Livorsi (a5) (a6), Jessina C. McGregor (a7), Lona Mody (a8), Rebekah W. Moehring (a9) (a10), Amy L. Pakyz (a11), Edward Stenehjem (a12), Julia E. Szymczak (a13) and Pranita D. Tamma (a14)...

Abstract

  • An abstract is not available for this content so a preview has been provided below. Please use the Get access link above for information on how to access this content.

Copyright

Corresponding author

Author for correspondence: Andrew M. Morris, Email: andrew.morris@sinaihealthsystem.ca

References

Hide All
1. Boucher, HW, Talbot, GH, Bradley, JS, et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 2009;48:112.
2. Antibiotic resistant threats in the United States. Centers for Disease Control and Prevention website. https://www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf3. Published 2013. Accessed September 17, 2019.
3. Polk, RE, Hohmann, SF, Medvedev, S, Ibrahim, O. Benchmarking risk-adjusted adult antibacterial drug use in 70 US academic medical center hospitals. Clin Infect Dis 2011;53:11001110.
4. Crnich, CJ, Jump, R, Trautner, B, Sloane, PD, Mody, L. Optimizing antibiotic stewardship in nursing homes: a narrative review and recommendations for improvement. Drugs Aging 2015;32:699716.
5. Baggs, J, Fridkin, SK, Pollack, LA, Srinivasan, A, Jernigan, JA. Estimating national trends in inpatient antibiotic use among US hospitals from 2006 to 2012. JAMA Intern Med 2016;176:16391648.
6. Weiner, LM, Fridkin, SK, Aponte-Torres, Z, et al. Vital signs: preventing antibiotic-resistant infections in hospitals—United States, 2014. Morb Mortal Wkly Rep 2016;65:235241.
7. Tamma, PD, Cosgrove, SE. Antimicrobial stewardship. Infect Dis Clin North Am 2011;25:245260.
8. Barlam, TF, Cosgrove, SE, Abbo, LM, et al. Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis 2016;62(10):e51e77.
9. Spivak, ES, Cosgrove, SE, Srinivasan, A. Measuring appropriate antimicrobial use: attempts at opening the black box. Clin Infect Dis 2016;63:16391644.
10. Ciccolini, M, Spoorenberg, V, Geerlings, SE, Prins, JM, Grundmann, H. Using an index-based approach to assess the population-level appropriateness of empirical antibiotic therapy. J Antimicrob Chemother 2015;70:286293.
11. Dresser, LD, Bell, CM, Steinberg, M, et al. Use of a structured panel process to define antimicrobial prescribing appropriateness in critical care. J Antimicrob Chemother 2018;73:246249.
12. Khan, AR, Khan, S, Zimmerman, V, Baddour, LM, Tleyjeh, IM. Quality and strength of evidence of the Infectious Diseases Society of America clinical practice guidelines. Clin Infect Dis 2010;51:11471156.
13. Lee, DH, Vielemeyer, O. Analysis of overall level of evidence behind Infectious Diseases Society of America practice guidelines. Arch Intern Med 2011;171:1822.
14. US Institute of Medicine. US Institute of Medicine Committee on Standards for Developing Trustworthy Clinical Practice Guidelines. Clinical Practice Guidelines We Can Trust. Washington, DC: IOM; 2011.
15. Wunderink, RG, Waterer, GW. Clinical practice: community-acquired pneumonia. N Engl J Med 2014;370:543551.
16. Morgan, DJ, Malani, P, Diekema, DJ. Diagnostic stewardship-leveraging the laboratory to improve antimicrobial use. JAMA 2017;318:607608.
17. Musher, DM, Montoya, R, Wanahita, A. Diagnostic value of microscopic examination of gram-stained sputum and sputum cultures in patients with bacteremic pneumococcal pneumonia. Clin Infect Dis 2004;39:165169.
18. Huang, DT, Yealy, DM, Filbin, MR, et al. Procalcitonin-guided use of antibiotics for lower respiratory tract infection. N Engl J Med 2018;379:236249.
19. Schuetz, P, Christ-Crain, M, Thomann, R, et al. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. JAMA 2009;302:10591066.
20. Mandell, LA, Wunderink, RG, Anzueto, A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007;44 suppl 2:S27S72.
21. Bradley, JS, Byington, CL, Shah, SS, et al. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis 2011;53(7):e25e76.
22. Mills, GD, Oehley, MR, Arrol, B. Effectiveness of beta lactam antibiotics compared with antibiotics active against atypical pathogens in non-severe community acquired pneumonia: meta-analysis. BMJ 2005;330(7489):456.
23. Eliakim-Raz, N, Robenshtok, E, Shefet, D, et al. Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adults. Cochrane Database Syst Rev 2012(9):CD004418.
24. Jain, S, Self, WH, Wunderink, RG, Team, CES. Community-acquired pneumonia requiring hospitalization. N Engl J Med 2015;373:2382.
25. Eljaaly, K, Alshehri, S, Aljabri, A, et al. Clinical failure with and without empiric atypical bacteria coverage in hospitalized adults with community-acquired pneumonia: a systematic review and meta-analysis. BMC Infect Dis 2017;17:385.
26. Garin, N, Genné, D, Carballo, S, et al. β-Lactam monotherapy vs β-lactam-macrolide combination treatment in moderately severe community-acquired pneumonia: a randomized noninferiority trial. JAMA Intern Med 2014;174:18941901.
27. Postma, DF, van Werkhoven, CH, van Elden, LJ, et al. Antibiotic treatment strategies for community-acquired pneumonia in adults. N Engl J Med 2015;372:13121323.
28. Avdic, E, Cushinotto, LA, Hughes, AH, et al. Impact of an antimicrobial stewardship intervention on shortening the duration of therapy for community-acquired pneumonia. Clin Infect Dis 2012;54:15811587.
29. Chastre, J, Wolff, M, Fagon, JY, et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA 2003;290:25882598.
30. Kalil, AC, Metersky, ML, Klompas, M, et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis 2016;63(5):e61e111.
31. Group, CCCT. A randomized trial of diagnostic techniques for ventilator-associated pneumonia. N Engl J Med 2006;355:26192630.
32. Nicolle, LE, Gupta, K, Bradley, SF, et al. Clinical practice guideline for the management of asymptomatic bacteriuria: 2019 update by the Infectious Diseases Society of Americaa. Clin Infect Dis 2019;68(10):e83e110.
33. Dull, RB, Friedman, SK, Risoldi, ZM, Rice, EC, Starlin, RC, Destache, CJ. Antimicrobial treatment of asymptomatic bacteriuria in noncatheterized adults: a systematic review. Pharmacotherapy 2014;34:941960.
34. Daniel, M, Keller, S, Mozafarihashjin, M, Pahwa, A, Soong, C. An implementation guide to reducing overtreatment of asymptomatic bacteriuria. JAMA Intern Med 2018;178:271276.
35. Nace, DA, Drinka, PJ, Crnich, CJ. Clinical uncertainties in the approach to long term care residents with possible urinary tract infection. J Am Med Dir Assoc 2014;15:133139.
36. Smaill, FM, Vazquez, JC. Antibiotics for asymptomatic bacteriuria in pregnancy. Cochrane Database Syst Rev 2015;8:CD000490.
37. Kazemier, BM, Koningstein, FN, Schneeberger, C, et al. Maternal and neonatal consequences of treated and untreated asymptomatic bacteriuria in pregnancy: a prospective cohort study with an embedded randomised controlled trial. Lancet Infect Dis 2015;15:13241333.
38. Moore, A, Doull, M, Grad, R, et al. Recommendations on screening for asymptomatic bacteriuria in pregnancy. CMAJ 2018;190(27):e823e30.
39. Gupta, K, Hooton, TM, Naber, KG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 2011;52(5):e103e120.
40. Leis, JA, Rebick, GW, Daneman, N, et al. Reducing antimicrobial therapy for asymptomatic bacteriuria among noncatheterized inpatients: a proof-of-concept study. Clin Infect Dis 2014;58:980983.
41. Dietz, J, Lo, TS, Hammer, K, Zegarra, M. Impact of eliminating reflex urine cultures on performed urine cultures and antibiotic use. Am J Infect Control 2016;44:17501751.
42. Epstein, L, Edwards, JR, Halpin, AL, et al. Evaluation of a novel intervention to reduce unnecessary urine cultures in intensive care units at a tertiary care hospital in Maryland, 2011–2014. Infect Control Hosp Epidemiol 2016;37:606609.
43. Talan, DA, Stamm, WE, Hooton, TM, et al. Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis pyelonephritis in women: a randomized trial. JAMA 2000;283:15831590.
44. Sandberg, T, Skoog, G, Hermansson, AB, et al. Ciprofloxacin for 7 days versus 14 days in women with acute pyelonephritis: a randomised, open-label and double-blind, placebo-controlled, non-inferiority trial. Lancet 2012;380:484490.
45. Moran, GJ, Krishnadasan, A, Mower, WR, et al. Effect of cephalexin plus trimethoprim-sulfamethoxazole vs cephalexin alone on clinical cure of uncomplicated cellulitis: a randomized clinical trial. JAMA 2017;317:20882096.
46. Hepburn, MJ, Dooley, DP, Skidmore, PJ, Ellis, MW, Starnes, WF, Hasewinkle, WC. Comparison of short-course (5 days) and standard (10 days) treatment for uncomplicated cellulitis. Arch Intern Med 2004;164:16691674.
47. Talan, DA, Mower, WR, Krishnadasan, A, et al. Trimethoprim-sulfamethoxazole versus placebo for uncomplicated skin abscess. N Engl J Med 2016;374:823832.
48. Daum, RS, Miller, LG, Immergluck, L, et al. A placebo-controlled trial of antibiotics for smaller skin abscesses. N Engl J Med 2017;376:25452555.
49. Uçkay, I, Berli, M, Sendi, P, Lipsky, BA. Principles and practice of antibiotic stewardship in the management of diabetic foot infections. Curr Opin Infect Dis 2019;32:95101.
50. Lipsky, BA, Berendt, AR, Cornia, PB, et al. 2012 infectious diseases society of america clinical practice guideline for the diagnosis and treatment of diabetic foot infections. J Am Podiatr Med Assoc 2013;103:27.
51. Solomkin, JS, Mazuski, JE, Bradley, JS, et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis 2010;50:133164.
52. Sawyer, RG, Claridge, JA, Nathens, AB, et al. Trial of short-course antimicrobial therapy for intraabdominal infection. N Engl J Med 2015;372:19962005.
53. Enzler, MJ, Berbari, E, Osmon, DR. Antimicrobial prophylaxis in adults. Mayo Clin Proc 2011;86:686701.
54. Carignan, A, Poulin, S, Martin, P, et al. Efficacy of secondary prophylaxis with vancomycin for preventing recurrent Clostridium difficile infections. Am J Gastroenterol 2016;111:18341840.
55. Van Hise, NW, Bryant, AM, Hennessey, EK, Crannage, AJ, Khoury, JA, Manian, FA. Efficacy of oral vancomycin in preventing recurrent Clostridium difficile infection in patients treated with systemic antimicrobial agents. Clin Infect Dis 2016;63:651653.
56. Bratzler, DW, Dellinger, EP, Olsen, KM, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Surg Infect (Larchmt) 2013;14:73156.
57. Wilson, W, Taubert, KA, Gewitz, M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2007;116:17361754.
58. Chambers, JB, Shanson, D, Venn, G, Pepper, J. NICE v world on endocarditis prophylaxis. BMJ 2011;342:d3531.
59. Thornhill, MH, Lockhart, PB, Prendergast, B, Chambers, JB, Shanson, D. NICE and antibiotic prophylaxis to prevent endocarditis. Br Dent J 2015;218:619621.
60. Cahill, TJ, Harrison, JL, Jewell, P, et al. Antibiotic prophylaxis for infective endocarditis: a systematic review and meta-analysis. Heart 2017;103:937944.
61. Tomblyn, M, Chiller, T, Einsele, H, et al. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transpl 2009;15:11431238.
62. Taplitz, RA, Kennedy, EB, Bow, EJ, et al. Antimicrobial prophylaxis for adult patients with cancer-related immunosuppression: ASCO and IDSA clinical practice guideline update. J Clin Oncol 2018;36:30433054.
63. Pogorzelska-Maziarz, M, Herzig, CT, Larson, EL, Furuya, EY, Perencevich, EN, Stone, PW. Implementation of antimicrobial stewardship policies in US hospitals: findings from a national survey. Infect Control Hosp Epidemiol 2015;36:261264.
64. O’Leary, EN, van Santen, KL, Webb, AK, Pollock, DA, Edwards, JR, Srinivasan, A. Uptake of antibiotic stewardship programs in US acute care hospitals: findings from the 2015 National Healthcare Safety Network Annual Hospital Survey. Clin Infect Dis 2017;65:17481750.
65. Davey, P, Marwick, CA, Scott, CL, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev 2017;2:CD003543.
66. Rzewuska, M, Charani, E, Clarkson, JE, et al. Prioritizing research areas for antibiotic stewardship programmes in hospitals: a behavioural perspective consensus paper. Clin Microbiol Infect 2019;25:163168.
67. Meeker, D, Linder, JA, Fox, CR, et al. Effect of behavioral interventions on inappropriate antibiotic prescribing among primary care practices: a randomized clinical trial. JAMA 2016;315:562570.
68. Meeker, D, Knight, TK, Friedberg, MW, et al. Nudging guideline-concordant antibiotic prescribing: a randomized clinical trial. JAMA Intern Med 2014;174:425431.
69. Arnold, SR, Straus, SE. Interventions to improve antibiotic prescribing practices in ambulatory care. Cochrane Database Syst Rev 2005;4:CD003539.
70. Losier, M, Ramsey, TD, Wilby, KJ, Black, EK, et al. A systematic review of antimicrobial stewardship interventions in the emergency department. Ann Pharmacother 2017;51:774790.
71. Feldstein, D, Sloane, PD, Feltner, C. Antibiotic stewardship programs in nursing homes: a systematic review. J Am Med Dir Assoc 2017.
72. Katz, MJ, Gurses, AP, Tamma, PD, Cosgrove, SE, Miller, MA, Jump, RLP. Implementing antimicrobial stewardship in long-term care settings: an integrative review using a human factors approach. Clin Infect Dis 2017;65:19431951.
73. Daneman, N, Gruneir, A, Bronskill, SE, et al. Prolonged antibiotic treatment in long-term care: role of the prescriber. JAMA Intern Med 2013;173:673682.
74. Ivers, N, Jamtvedt, G, Flottorp, S, et al. Audit and feedback: effects on professional practice and healthcare outcomes. Cochrane Database Syst Rev 2012(6):CD000259.
75. Naylor, NR, Zhu, N, Hulscher, M, Holmes, A, Ahmad, R, Robotham, JV. Is antimicrobial stewardship cost-effective? A narrative review of the evidence. Clin Microbiol Infect 2017;23:806811.
76. Cosgrove, SE, Seo, SK, Bolon, MK, et al. Evaluation of postprescription review and feedback as a method of promoting rational antimicrobial use: a multicenter intervention. Infect Control Hosp Epidemiol 2012;33:374380.
77. Meeker, D, Linder, JA, Fox, CR, et al. Effect of behavioral interventions on inappropriate antibiotic prescribing among primary care practices: a randomized clinical trial. JAMA 2016;315:562570.
78. Hallsworth, M, Chadborn, T, Sallis, A, et al. Provision of social norm feedback to high prescribers of antibiotics in general practice: a pragmatic national randomised controlled trial. Lancet 2016;387:17431752.
79. Hurst, AL, Child, J, Pearce, K, Palmer, C, Todd, JK, Parker, SK. Handshake stewardship: a highly effective rounding-based antimicrobial optimization service. Pediatr Infect Dis J 2016;35:11041110.
80. Hurst, AL, Child, J, Parker, SK. Intervention and acceptance rates support handshake-stewardship strategy. J Pediatric Infect Dis Soc 2019;8:162165.
81. Curtis, CE, Al Bahar, F, Marriott, JF. The effectiveness of computerised decision support on antibiotic use in hospitals: a systematic review. PLoS One 2017;12(8):e0183062.
82. Rawson, TM, Moore, LSP, Hernandez, B, et al. A systematic review of clinical decision support systems for antimicrobial management: are we failing to investigate these interventions appropriately? Clin Microbiol Infect 2017;23:524532.
83. Cresswell, K, Mozaffar, H, Shah, S, Sheikh, A. Approaches to promoting the appropriate use of antibiotics through hospital electronic prescribing systems: a scoping review. Int J Pharm Pract 2017;25:517.
84. Baysari, MT, Lehnbom, EC, Li, L, Hargreaves, A, Day, RO, Westbrook, JI. The effectiveness of information technology to improve antimicrobial prescribing in hospitals: a systematic review and meta-analysis. Int J Med Inform 2016;92:1534.
85. Bond, SE, Chubaty, AJ, Adhikari, S, et al. Outcomes of multisite antimicrobial stewardship programme implementation with a shared clinical decision support system. J Antimicrob Chemother 2017;72:21102118.
86. Teixeira Rodrigues, A, Roque, F, Falcão, A, Figueiras, A, Herdeiro, MT. Understanding physician antibiotic prescribing behaviour: a systematic review of qualitative studies. Int J Antimicrob Agents 2013;41:203212.
87. Mustafa, M, Wood, F, Butler, CC, Elwyn, G. Managing expectations of antibiotics for upper respiratory tract infections: a qualitative study. Ann Fam Med 2014;12:2936.
88. Broom, A, Kirby, E, Gibson, AF, Post, JJ, Broom, J. Myth, Manners, and medical ritual: defensive medicine and the fetish of antibiotics. Qual Health Res 2017;27:19942005.
89. Charani, E, Castro-Sanchez, E, Sevdalis, N, et al. Understanding the determinants of antimicrobial prescribing within hospitals: the role of “prescribing etiquette.” Clin Infect Dis 2013;57:188196.
90. Papoutsi, C, Mattick, K, Pearson, M, Brennan, N, Briscoe, S, Wong, G. Social and professional influences on antimicrobial prescribing for doctors-in-training: a realist review. J Antimicrob Chemother 2017;72:24182430.
91. Mangione-Smith, R, McGlynn, EA, Elliott, MN, McDonald, L, Franz, CE, Kravitz, RL. Parent expectations for antibiotics, physician-parent communication, and satisfaction. Arch Pediatr Adolesc Med 2001;155:800806.
92. Mangione-Smith, R, McGlynn, EA, Elliott, MN, Krogstad, P, Brook, RH. The relationship between perceived parental expectations and pediatrician antimicrobial prescribing behavior. Pediatrics 1999;103:711718.
93. Mangione-Smith, R, Elliott, MN, Stivers, T, McDonald, LL, Heritage, J. Ruling out the need for antibiotics: are we sending the right message? Arch Pediatr Adolesc Med 2006;160:945952.
94. Légaré, F, Labrecque, M, Cauchon, M, Castel, J, Turcotte, S, Grimshaw, J. Training family physicians in shared decision-making to reduce the overuse of antibiotics in acute respiratory infections: a cluster randomized trial. CMAJ 2012;184(13):e726e734.
95. Michie, S, Richardson, M, Johnston, M, et al. The behavior change technique taxonomy (v1) of 93 hierarchically clustered techniques: building an international consensus for the reporting of behavior change interventions. Ann Behav Med 2013;46:8195.
96. Meeker, D, Knight, TK, Friedberg, MW, et al. Nudging guideline-concordant antibiotic prescribing: a randomized clinical trial. JAMA Intern Med 2014;174:425431.
97. Hulscher, ME, Grol, RP, van der Meer, JW. Antibiotic prescribing in hospitals: a social and behavioural scientific approach. Lancet Infect Dis 2010;10:167175.
98. Smith, MJ, Gerber, JS, Hersh, AL. Inpatient antimicrobial stewardship in pediatrics: a systematic review. J Pediatric Infect Dis Soc 2015;4(4):e127e135.
99. Mertz, D, Brooks, A, Irfan, N, Sung, M. Antimicrobial stewardship in the intensive care setting—a review and critical appraisal of the literature. Swiss Med Wkly 2015;145:w14220.
100. Karanika, S, Paudel, S, Grigoras, C, Kalbasi, A, Mylonakis, E. Systematic review and meta-analysis of clinical and economic outcomes from the implementation of hospital-based antimicrobial stewardship programs. Antimicrob Agents Chemother 2016;60:48404852.
101. Honda, H, Ohmagari, N, Tokuda, Y, Mattar, C, Warren, DK. Antimicrobial stewardship in inpatient settings in the Asia Pacific region: a systematic review and meta-analysis. Clin Infect Dis 2017;64 suppl 2:S119S126.
102. Drekonja, DM, Filice, GA, Greer, N, et al. Antimicrobial stewardship in outpatient settings: a systematic review. Infect Control Hosp Epidemiol 2015;36:142152.
103. Feldstein, D, Sloane, PD, Feltner, C. Antibiotic stewardship programs in nursing homes: a systematic review. J Am Med Dir Assoc 2018;19:110116.
104. Losier, M, Ramsey, TD, Wilby, KJ, Black, EK. A systematic review of antimicrobial stewardship interventions in the emergency department. Ann Pharmacother 2017;51:774790.
105. Gerber, JS, Prasad, PA, Fiks, AG, et al. Durability of benefits of an outpatient antimicrobial stewardship intervention after discontinuation of audit and feedback. JAMA 2014;312:25692570.
106. Ament, SM, de Groot, JJ, Maessen, JM, Dirksen, CD, van der Weijden, T, Kleijnen, J. Sustainability of professionals’ adherence to clinical practice guidelines in medical care: a systematic review. BMJ Open 2015;5(12):e008073.
107. Linder, JA, Meeker, D, Fox, CR, et al. Effects of behavioral interventions on inappropriate antibiotic prescribing in primary care 12 months after stopping interventions. JAMA 2017;318:13911392.
108. Bishop, J, Kong, DC, Schulz, TR, Thursky, KA, Buising, KL. Meeting the challenge for effective antimicrobial stewardship programs in regional, rural and remote hospitals—what can we learn from the published literature? Rural Remote Health 2018;18:4442.
109. Stenehjem, E, Hersh, AL, Buckel, WR, et al. Impact of implementing antibiotic stewardship programs in 15 small hospitals: a cluster-randomized intervention. Clin Infect Dis 2018;67:525532.
110. Kullar, R, Yang, H, Grein, J, Murthy, R. A roadmap to implementing antimicrobial stewardship principles in long-term care facilities (LTCFs): Collaboration between an acute-care hospital and LTCFs. Clin Infect Dis 2018;66:13041312.
111. Mody, L, Washer, L, Flanders, S. Can infection prevention programs in hospitals and nursing facilities be integrated? From silos to partners. JAMA 2018;319:10891090.
112. Dik, JW, Vemer, P, Friedrich, AW, et al. Financial evaluations of antibiotic stewardship programs-a systematic review. Front Microbiol 2015;6:317.
113. Olans, RN, Olans, RD, DeMaria, A. The critical role of the staff nurse in antimicrobial stewardship—unrecognized, but already there. Clin Infect Dis 2016;62:8489.
114. Jeffs, L, Law, MP, Zahradnik, M, et al. Engaging nurses in optimizing antimicrobial use in ICUs: a qualitative study. J Nurs Care Qual 2018;33:173179.
115. Pulcini, C, Morel, CM, Tacconelli, E, et al. Human resources estimates and funding for antibiotic stewardship teams are urgently needed. Clin Microbiol Infect 2017;23:785787.
116. Morris, AM, Rennert-May, E, Dalton, B, et al. Rationale and development of a business case for antimicrobial stewardship programs in acute care hospital settings. Antimicrob Resist Infect Control 2018;7:104.
117. Doernberg, SB, Abbo, LM, Burdette, SD, et al. Essential resources and strategies for antibiotic stewardship programs in the acute care setting. Clin Infect Dis 2018;67:11681174.
118. Echevarria, K, Groppi, J, Kelly, AA, Morreale, AP, Neuhauser, MM, Roselle, GA. Development and application of an objective staffing calculator for antimicrobial stewardship programs in the Veterans Health Administration. Am J Health Syst Pharm 2017;74:17851790.
119. Ng, SC, Ching, JY, Chan, V, et al. Diagnostic accuracy of faecal immunochemical test for screening individuals with a family history of colorectal cancer. Aliment Pharmacol Ther 2013;38:835841.
120. Morris, AM, Brener, S, Dresser, L, et al. Use of a structured panel process to define quality metrics for antimicrobial stewardship programs. Infect Control Hosp Epidemiol 2012;33:500506.
121. Aldeyab, MA, McElnay, JC, Scott, MG, et al. A modified method for measuring antibiotic use in healthcare settings: implications for antibiotic stewardship and benchmarking. J Antimicrob Chemother 2014;69:11321141.
122. Tacconelli, E, Cataldo, MA, Paul, M, et al. STROBE-AMS: recommendations to optimise reporting of epidemiological studies on antimicrobial resistance and informing improvement in antimicrobial stewardship. BMJ Open 2016;6(2):e010134.
123. van Santen, KL, Edwards, JR, Webb, AK, et al. The standardized antimicrobial administration ratio: a new metric for measuring and comparing antibiotic use. Clin Infect Dis 2018;67:179185.
124. Yu, KC, Moisan, E, Tartof, SY, et al. Benchmarking inpatient antimicrobial use: a comparison of risk-adjusted observed-to-expected ratios. Clin Infect Dis 2018;67:16771685.
125. Fridkin, SK, Srinivasan, A. Implementing a strategy for monitoring inpatient antimicrobial use among hospitals in the United States. Clin Infect Dis 2014;58:401406.
126. Sanchez, GV, Fleming-Dutra, KE, Roberts, RM, Hicks, LA. Core elements of outpatient antibiotic stewardship. MMWR Recomm Rep 2016;65(6):112.
127. Dobson, EL, Klepser, ME, Pogue, JM, et al. Outpatient antibiotic stewardship: Interventions and opportunities. J Am Pharm Assoc 2017;57 464473.
128. Akpan, MR, Ahmad, R, Shebl, NA, Ashiru-Oredope, D. A review of quality measures for assessing the impact of antimicrobial stewardship programs in hospitals. Antibiotics (Basel) 2016;5(1):pii:E5. doi: 10.3390/antibiotics5010005.
129. Yogo, N, Haas, MK, Knepper, BC, Burman, WJ, Mehler, PS, Jenkins, TC. Antibiotic prescribing at the transition from hospitalization to discharge: a target for antibiotic stewardship. Infect Control Hosp Epidemiol 2015;36:474478.
130. Scarpato, SJ, Timko, DR, Cluzet, VC, et al. An evaluation of antibiotic prescribing practices upon hospital discharge. Infect Control Hosp Epidemiol 2017;38:353355.
131. McGowan, JE. Antimicrobial stewardship--the state of the art in 2011: focus on outcome and methods. Infect Control Hosp Epidemiol. 2012;33(4):331–7.
132. Dodds Ashley, ES, Kaye, KS, DePestel, DD, Hermsen, ED. Antimicrobial stewardship: philosophy versus practice. Clin Infect Dis 2014;59 suppl 3:S112S121.
133. Jones, BE, Haroldsen, C, Madaras-Kelly, K, et al. In data we trust? Comparison of electronic versus manual abstraction of antimicrobial prescribing quality metrics for hospitalized veterans with pneumonia. Med Care 2018;56:626633.
134. Moehring, RW, Anderson, DJ, Cochran, RL, et al. Expert consensus on metrics to assess the impact of patient-level antimicrobial stewardship interventions in acute-care settings. Clin Infect Dis 2017;64:377383.
135. Matthaiou, DK, Ntani, G, Kontogiorgi, M, Poulakou, G, Armaganidis, A, Dimopoulos, G. An ESICM systematic review and meta-analysis of procalcitonin-guided antibiotic therapy algorithms in adult critically ill patients. Intens Care Med 2012;38:940949.
136. Schuts, EC, Hulscher, MEJL, Mouton, JW, et al. Current evidence on hospital antimicrobial stewardship objectives: a systematic review and meta-analysis. Lancet Infect Dis 2016;16:847856.
137. Baur, D, Gladstone, BP, Burkert, F, et al. Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis. Lancet Infect Dis 2017;17:9901001.
138. Lederer, DJ, Bell, SC, Branson, RD, et al. Control of confounding and reporting of results in causal inference studies. guidance for authors from editors of respiratory, sleep, and critical care journals. Ann Am Thorac Soc 2019;16:2228.
139. Evans, SR, Rubin, D, Follmann, D, et al. Desirability of outcome ranking (DOOR) and response adjusted for duration of antibiotic risk (RADAR). Clin Infect Dis 2015;61:800806.

Research needs in antibiotic stewardship

  • Andrew M. Morris (a1) (a2), Michael S. Calderwood (a3), Scott K. Fridkin (a4), Daniel J. Livorsi (a5) (a6), Jessina C. McGregor (a7), Lona Mody (a8), Rebekah W. Moehring (a9) (a10), Amy L. Pakyz (a11), Edward Stenehjem (a12), Julia E. Szymczak (a13) and Pranita D. Tamma (a14)...

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed